Form D · Biotechnology
FLUGEN INC
Madison, WI · CIK 0001451665
Offering snapshot reported May 1, 2020 · SEC filing
- Reported sold
- $8.18M Offering amount: $8.5M
- Investors reported
- 47 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 24, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 1, 2020 | Initial | $8,184,058 | No comparison | 47 | SEC filing |
| Nov 13, 2018 | Initial | $5,583,000 | No comparison | 36 | SEC filing |
| Aug 1, 2017 | Initial | $5,500,000 | No comparison | 25 | SEC filing |
| Apr 11, 2017 | Amendment | $11,423,860 | $2,000,000vs Aug 20, 2015 | 29 | SEC filing |
| Aug 20, 2015 | Initial | $9,423,860 | No comparison | 27 | SEC filing |
| May 30, 2014 | Initial | $3,228,479 | No comparison | 15 | SEC filing |
| Oct 6, 2011 | Amendment | $3,276,853 | $828,815vs Feb 11, 2011 | 15 | SEC filing |
| Feb 11, 2011 | Amendment | $2,448,038 | No comparison | 14 | SEC filing |
| Nov 26, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Debt, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-366135
The exercise price with respect to the warrants will be paid to the Issuer, if and when, the warrants are exercised in accordance with their terms.
Source: Form D, filed May 1, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Pamuk Bilsel | Executive |
| C. Boyd Clarke | Director |
| Phillip M. Halpern | Director |
| Craig Heim | Director |
| Erik Iverson | Director |
| Yoshihiro Kawaoka | Director |
| Terence F. Kelly | Director |
| Terrence Kelly | Director |
| Scott L. Klug | Director |
| Frederick Mancheski | Director |
| Deven Mc Glenn | Director |
| Gabriele Neumann | Director |
| David Newberg | Director |
| Eric Patzer | Director |
| Paul V. Radspinner | Director, Executive |
| Bryan Renk | Director |
| Russell R. Smestad | Director |
| Dan Stinchcomb | Director |
| Michael Wagner | Director |
| David G. Walsh | Director |
| Paul Weiss | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
597 Science Drive
Madison, WI, 53711
Madison, WI, 53711